Vanda Pharmaceuticals Inc (VNDA) — Net Asset Quality Index
Vanda Pharmaceuticals Inc (VNDA) has a Net Asset Quality Index of 66.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $488.95 Million minus total liabilities of $161.76 Million yields net assets of $327.19 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Vanda Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Vanda Pharmaceuticals Inc Net Asset Quality Index Over Time (2004–2025)
This chart shows how Vanda Pharmaceuticals Inc's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the index stands at 66.9%, representing net assets of $327.19 Million against total assets of $488.95 Million USD. Explore Vanda Pharmaceuticals Inc (VNDA) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Vanda Pharmaceuticals Inc (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for Vanda Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Vanda Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.9% | $327.19 Million | $488.95 Million | $161.76 Million | ▼ -15.2 pp |
| 2024 | 82.1% | $538.55 Million | $656.20 Million | $117.66 Million | ▼ -2.0 pp |
| 2023 | 84.0% | $544.91 Million | $648.44 Million | $103.53 Million | ▲ +0.9 pp |
| 2022 | 83.1% | $527.20 Million | $634.25 Million | $107.05 Million | ▼ -1.9 pp |
| 2021 | 85.0% | $504.93 Million | $593.79 Million | $88.86 Million | ▲ +0.1 pp |
| 2020 | 85.0% | $453.27 Million | $533.46 Million | $80.19 Million | ▲ +0.0 pp |
| 2019 | 85.0% | $410.94 Million | $483.75 Million | $72.80 Million | ▲ +2.0 pp |
| 2018 | 82.9% | $275.42 Million | $332.13 Million | $56.71 Million | ▲ +19.0 pp |
| 2017 | 64.0% | $131.39 Million | $205.43 Million | $74.04 Million | ▲ +1.5 pp |
| 2016 | 62.4% | $131.33 Million | $210.37 Million | $79.04 Million | ▼ 0.0 pp |
| 2015 | 62.4% | $133.03 Million | $213.05 Million | $80.02 Million | ▼ -31.2 pp |
| 2014 | 93.7% | $160.82 Million | $171.70 Million | $10.89 Million | ▲ +62.9 pp |
| 2013 | 30.8% | $44.12 Million | $143.35 Million | $99.22 Million | ▲ +23.5 pp |
| 2012 | 7.3% | $9.90 Million | $135.45 Million | $125.54 Million | ▼ -11.0 pp |
| 2011 | 18.3% | $33.47 Million | $182.62 Million | $149.14 Million | ▲ +0.6 pp |
| 2010 | 17.7% | $37.73 Million | $213.10 Million | $175.37 Million | ▲ +7.5 pp |
| 2009 | 10.2% | $23.03 Million | $225.71 Million | $202.68 Million | ▼ -82.0 pp |
| 2008 | 92.2% | $46.02 Million | $49.93 Million | $3.91 Million | ▲ +5.7 pp |
| 2007 | 86.4% | $83.73 Million | $96.86 Million | $13.13 Million | ▲ +12.7 pp |
| 2006 | 73.8% | $26.76 Million | $36.26 Million | $9.50 Million | ▼ -12.0 pp |
| 2005 | 85.8% | $30.66 Million | $35.75 Million | $5.09 Million | ▼ -4.0 pp |
| 2004 | 89.8% | $15.94 Million | $17.75 Million | $1.81 Million | — |